While there are no data sources on Long COVID in prison, experts suspect rates of the disease may be higher there than in the general population. They face high reinfection risks and poor access to me...

While there are no data sources on Long COVID in prison, experts suspect rates of the disease may be higher there than in the general population. They face high reinfection risks and poor access to me...

While there are no data sources on Long COVID in prison, experts suspect rates of the disease may be higher there than in the general population. They face high reinfection risks and poor access to me...

Air purifier lending libraries, mask blocs, and mutual aid initiatives are just a few of the ways activists are making spaces where LGBTQ+ people gather more COVID-safe.

The National Association of Science Writers and its Awards Committee are pleased to announce the winners of the <strong>2026 NASW Science in Society Journalism Awards.</strong> This year, NASW is awar...

The trial, run by researchers at McMaster University in Canada, is testing the Lightning Process, a pseudoscientific mind-body program that outside experts have heavily criticized.

The trial, run by researchers at McMaster University in Canada, is testing the Lightning Process, a pseudoscientific mind-body program that outside experts have heavily criticized.

The trial, run by researchers at McMaster University in Canada, is testing the Lightning Process, a pseudoscientific mind-body program that outside experts have heavily criticized.

The Telegraph published an article titled, “How having a disability became cool." This article shores up the government narrative that rising rates of disability are being driven, not by the ongoing a...

The Telegraph published an article titled, “How having a disability became cool." This article shores up the government narrative that rising rates of disability are being driven, not by the ongoing a...

Corporate interests have had more say in our behaviors toward both COVID-19 and the climate crisis than any evidence-based public health response.

While the phase 2 clinical trial results, shared by BioVie in a webinar on Tuesday, have yet to be peer-reviewed, investigators say they can inform a confirmatory phase 3 trial.

Despite nearly 1.3 million deaths and counting, there is still not a national memorial for the pandemic. Our informal memorial in the middle of the Mojave Desert is one small way to remember those we’...

A new U.S. clinical trials program called PROBE-PASC was announced on Friday at a Long COVID conference in Amsterdam. The program received initial funding of $8 million from a Department of Defense (D...

Despite prior experience working in public health, I’ve faced challenges getting care for Long COVID and chronic seizures.